The PhD Program in Advanced Therapies and Experimental Pharmacology represents a prestigious educational pathway designed to train highly qualified researchers and professionals in the biomedical field. The program is structured to provide advanced skills in both preclinical and clinical settings, with a specific focus on the development of innovative therapies. 

One of the distinctive features of the PhD Program is its interdisciplinary, multidisciplinary, and transdisciplinary approach, integrating experimental pharmacology (cellular, tissue, and genetic) with advanced therapies. This approach combines a strong theoretical foundation with practical clinical applications, preparing doctoral candidates to tackle the challenges of modern biomedical research. 

The educational pathway is designed to offer comprehensive training, ranging from basic research to applied experimentation while promoting the development of cross-disciplinary skills essential for scientific innovation. The training activities, meticulously curated, include a wide array of learning opportunities, fostering both personal and professional growth for doctoral candidates. 

The PhD Program places particular emphasis on internationalization, supporting collaborations with prestigious universities and research centers abroad and encouraging participation in international research programs and projects. This global perspective, combined with an extensive network of partnerships, enhances the value of the doctoral candidates' journey, broadening their professional horizons. 

The primary goal of the PhD Program is to strengthen participants' competencies and create new opportunities, both in academia and in multidisciplinary settings, opening the door to innovative and high-profile career paths in research.